Showing results (401-410 of 8,120) with videos related to

Sort By:
Pageof 812
Haematologica|December 17, 2014
Daratumumab-mediated lysis of primary multiple myeloma cells is enhanced in combination with the human anti-KIR antibody IPH2102 and lenalidomideInger S Nijhof, Jeroen J Lammerts van Bueren, Berris van Kessel, et al.
Haematologica|January 18, 2015
ASXL1 mutations in younger adult patients with acute myeloid leukemia: a study by the German-Austrian Acute Myeloid Leukemia Study GroupPeter Paschka, Richard F Schlenk, Verena I Gaidzik, et al.
Haematologica|January 18, 2015
Multifunctional human CD56 low CD16 low natural killer cells are the prominent subset in bone marrow of both healthy pediatric donors and leukemic patientsHelena Stabile, Paolo Nisti, Stefania Morrone, et al.
Haematologica|August 8, 2015
TIGIT-positive circulating follicular helper T cells display robust B-cell help functions: potential role in sickle cell alloimmunizationEmmanuelle Godefroy, Hui Zhong, Petra Pham, et al.
Haematologica|January 29, 2016
Prevalence and characteristics of central nervous system involvement by chronic lymphocytic leukemiaPaolo Strati, Joon H Uhm, Timothy J Kaufmann, et al.
Haematologica|January 16, 2016
High-risk HLA alleles for severe acute graft-versus-host disease and mortality in unrelated donor bone marrow transplantationSatoko Morishima, Koichi Kashiwase, Keitaro Matsuo, et al.
Haematologica|January 24, 2016
Extracellular vesicle miR-7977 is involved in hematopoietic dysfunction of mesenchymal stromal cells via poly(rC) binding protein 1 reduction in myeloid neoplasmsHiroto Horiguchi, Masayoshi Kobune, Shohei Kikuchi, et al.
Haematologica|January 24, 2016
Expression of a dominant T-cell receptor can reduce toxicity and enhance tumor protection of allogeneic T-cell therapyAngelika Holler, Mathias Zech, Sara Ghorashian, et al.
Haematologica|January 2, 2016
Humanized hemato-lymphoid system miceAlexandre P A Theocharides, Anthony Rongvaux, Kristin Fritsch, et al.
Haematologica|January 2, 2016
Effects of anti-NKG2A antibody administration on leukemia and normal hematopoietic cellsLoredana Ruggeri, Elena Urbani, Pascale André, et al.
Pageof 812